These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9701851)

  • 1. Anti-infective strategies in neutropenic patients.
    Maertens J; Boogaerts MA
    Acta Clin Belg; 1998 Jun; 53(3):168-77. PubMed ID: 9701851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I; Sanz MA
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monotherapy for empirical management of febrile neutropenic patients.
    Rubin M; Pizzo PA
    NCI Monogr; 1990; (9):111-6. PubMed ID: 2160613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic therapy for gram-negative bacteremia.
    Calandra T; Cometta A
    Infect Dis Clin North Am; 1991 Dec; 5(4):817-34. PubMed ID: 1783770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current treatments for infection in neutropenic patients with hematologic malignancy.
    Greene JN; Linch DC; Miller CB
    Oncology (Williston Park); 2000 Aug; 14(8 Suppl 6):31-4. PubMed ID: 10989822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current guidelines for the treatment of severe pneumonia and sepsis.
    Bodmann KF
    Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis and treatment of bacterial infections: do we need new strategies?
    Micozzi A; Bucaneve G
    Rev Clin Exp Hematol; 2005 Dec; 9(2):E4. PubMed ID: 16864118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirical antimicrobial treatment for chemotherapy-induced febrile neutropenia.
    Bal AM; Gould IM
    Int J Antimicrob Agents; 2007 May; 29(5):501-9. PubMed ID: 17346939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of infection in granulopenic patients. Lessons from international studies].
    Beytout J; Travade P; Petit MF
    Presse Med; 1988 Oct; 17(37):1950-3. PubMed ID: 2973594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of the febrile neutropenic patient.
    Picazo JJ;
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Standards, Options, and Recommendations for the management of brief neutropenias. Fedération Nationale des Centres de Lutte Contre le Cancer].
    Biron P; Fuhrmann C; Escande MC; Blanc-Vincent MP; Crokaert F; Béal J; Bussy V; Lesimple T; Pottecher B; Raveneau J; Senet JM; Viot M
    Bull Cancer; 1998 Aug; 85(8):695-711. PubMed ID: 9754078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients.
    Glasmacher A; von Lilienfeld-Toal M; Schulte S; Hahn C; Schmidt-Wolf IG; Prentice A
    Clin Microbiol Infect; 2005 Oct; 11 Suppl 5():17-23. PubMed ID: 16138815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antimicrobial prophylaxis and therapy in neutropenia].
    Link H
    Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current issues in the treatment of resistant bloodstream infections.
    Wade JC
    Oncology (Williston Park); 2000 Aug; 14(8 Suppl 6):35-9. PubMed ID: 10989823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Empirical antibiotic therapy for febrile neutropenia].
    Kridel R; Van Delden C; Calandra T; Marchetti O
    Rev Med Suisse; 2008 Apr; 4(152):914, 916-9. PubMed ID: 18578432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empiric monotherapy in neutropenia: a realistic goal?
    Del Favero A; Bucaneve G; Menichetti F
    Scand J Infect Dis Suppl; 1995; 96():34-7. PubMed ID: 7652501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.